-
Tue17Nov2026Sat21Nov2026
-
Wed25Nov2026Fri27Nov2026
-
Thu03Dec2026Sat05Dec2026
-
Tue26Jan2027Thu28Jan2027
-
Wed17Mar2027Sun21Mar2027
-
Tue06Apr2027Thu08Apr2027
-
Thu27May2027Fri28May2027
-
Wed02Jun2027Sat05Jun2027
Latest News
Penumbra receives US FDA clearance for Lightning CAVT technology for the...
Penumbra has announced that the US Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to its...
Features
Multinational trial of low-cost drug targets primary inflammation in PAD patients
As the global burden of peripheral arterial disease (PAD) continues to rise, so too does the need for strategies to reduce an “unacceptably high”...
Why the ESVS focused update on claudication recommends selective use of...
In response to Peter Schneider (San Francisco, USA), Thomas Zeller (Bad Krozingen, Germany) and colleagues' recent comment article for Vascular News on the European...
Videos
In part two of a Charing Cross (CX) Symposium special roundtable discussion on the use of drug-based technology use in the lower extremity, Peter...





















